ALKS
ALKS
NASDAQ · Biotechnology

Alkermes Plc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$34.99
-0.41 (-1.16%)
As of May 9, 1:16 AM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 20 83%
Hold 4 17%
Sell 0 0%
Price Target
Analyst Price Target +261.2% upside
Low Target $90.34
Average Target $126.40
High Target $146.79
Current Price $34.99
Current
$34.99
Target
$126.40
$90.34 $126.40 avg $146.79
Scenario Analysis
Bear Case
$90.34
158.2%
Low target
Base Case
$126.40
+261.2%
Avg target
Bull Case
$146.79
+319.5%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$36.60
-4.4% from high
52-Week Low
$25.17
+39.0% from low
50-Day SMA
$31.02
+12.8% vs SMA
200-Day SMA
$29.87
+17.1% vs SMA
RSI (14)
32.3
Neutral
Target vs 52W High
$126.40
+245.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%